Research programme: PPAR agonists - Daiichi Sankyo
Latest Information Update: 16 Jul 2016
At a glance
- Originator Daiichi Sankyo Company
- Class Acetic acids
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Metabolic syndrome; Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Metabolic-syndrome in Japan (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Japan (PO)
- 03 Sep 2007 Preclinical trials in Metabolic syndrome in Japan (PO)